Table 4 Correlations between concentrations of CRP and clinical parameters of EOC patients.
From: Clinical usefulness of high levels of C-reactive protein for diagnosing epithelial ovarian cancer
Overall (n = 91) | CRP < 9.8 mg/L (n = 25) | CRP > 9.8 mg/L (n = 66) | p | |||
|---|---|---|---|---|---|---|
N | % | N | % | |||
Age | 0.641 | |||||
≤ 55 | 48 | 12 | 25 | 36 | 75 | |
> 55 | 43 | 13 | 30 | 30 | 70 | |
Histopathologic differentiation | 0.721 | |||||
Poor | 25 | 6 | 24 | 19 | 76 | |
Moderate | 34 | 11 | 32 | 23 | 68 | |
Good | 32 | 8 | 25 | 24 | 75 | |
FIGO stage | < 0.05*1 | |||||
I | 23 | 4 | 17 | 19 | 83 | |
II | 29 | 4 | 14 | 25 | 86 | |
III | 18 | 8 | 44 | 10 | 56 | |
IV | 21 | 9 | 43 | 12 | 57 | |
Histologic type | 0.991 | |||||
Serous | 42 | 11 | 26 | 31 | 74 | |
Mucinous | 25 | 7 | 28 | 18 | 72 | |
Endometrioid | 17 | 5 | 29 | 12 | 71 | |
Clear cell | 7 | 2 | 28 | 5 | 72 | |
Tumor size | < 0.05*1 | |||||
≤ 5 cm | 38 | 5 | 13 | 33 | 87 | |
5–10 cm | 46 | 18 | 39 | 28 | 61 | |
> 10 cm | 7 | 2 | 28 | 5 | 72 | |